The Summer Rosacea Review is now online. Highlights of this issue include results from a recent National Rosacea Society patient survey, which documents that rosacea encompasses a wide range of potential signs and symptoms, as well as treatment options for the flushing and redness of subtype 1 (erythematotelangiectatic) rosacea.
Not only is rosacea now estimated to affect more than 16 million Americans, but a new survey by the National Rosacea Society documents the unusually wide range of potential signs and symptoms that may be associated with the disorder.
A new study has found there may be a link between ocular rosacea and bacteria associated with Demodex mites, microscopic inhabitants of normal skin that tend to occur in much greater numbers in those with rosacea.
In the recently published study of 59 rosacea patients, Dr. Jianjing Li and colleagues at the Ocular Surface Center in Miami found a significant correlation between facial rosacea, infestation of the eyes with Demodex mites and reaction to certain mite-related organisms previously shown to stimulate an immune response in rosacea sufferers.1
While many adults still look forward to summer as eagerly as schoolchildren, new survey results show that increased exposure to sun and hot weather can wreak havoc on those with rosacea, a widespread, red-faced skin disorder now estimated to affect more than 16 million Americans. The survey also found that a variety of common heat sources can affect the condition year-round.
You asked for it and now you have it. In the ongoing Opinion Survey on Rosacea.org content, 88 percent of the respondents have said they are “very interested” in information on medical treatments for rosacea.
While some signs and symptoms of rosacea can be challenging to control, effective medical therapies have been extensively studied and approved for the treatment of the bumps and pimples of subtype 2 (papulopustular) rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society.1
The National Rosacea Society (NRS) has awarded funding to three new studies and continues to fund three ongoing studies as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this potentially life-disruptive disorder.
The National Rosacea Society (NRS) announced today that the estimated number of Americans now suffering from rosacea has increased to 16 million, while untold millions more may be in temporary remission. April is designated as Rosacea Awareness Month by the NRS to alert the public to the warning signs of this red-faced, acne-like and often life-disruptive disorder, and the importance of seeking early diagnosis and treatment.
Although subtype 3 (phymatous) rosacea often involves excess tissue, it can be effectively treated with a range of options appropriate for the severity of the case, according to the standard management options for rosacea recently published by the National Rosacea Society.1
Although the number of people with rosacea continues to rise with the growth and aging of the U.S. population, most fail to recognize the warning signs of this potentially life-disruptive disorder now estimated to affect well over 14 million Americans. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to alert the public to the signs and symptoms of this chronic and conspicuous facial condition and to emphasize the importance of seeking medical help.
Rosacea is the featured topic of a recent segment on ABC-TV’s Good Morning America Health. Dr. Doris Day, clinical assistant professor of dermatology at New York University, discusses signs and symptoms of the disorder as well as treatment options and avoidance of triggers.
To watch the entire interview, click here.
Heat often brings on the signs and symptoms of rosacea, and this can be a problem even in the frosty winter months, according to a recent National Rosacea Society survey of 424 rosacea patients.
Researchers have now identified the molecular pathway for flushing caused by niacin -- also known as vitamin B3 or nicotinic acid, and found in many foods -- according to a study recently completed by Dr. Robert Walters and colleagues at Duke University and funded by the National Rosacea Society (NRS). The new findings may lead to future improvements in the treatment or prevention of rosacea, which is commonly associated with flushing.
The National Rosacea Society constantly strives to provide relevant, accurate and up-to-date information on all aspects of this widespread disorder. To help make Rosacea.org as useful as possible, please give us your input on current and possible future content. The information you provide will serve as a guide for the continuing expansion of the site. Thank you very much for your help.
To take the survey, click here.
The best offense against a common skin problem such as rosacea is a strong defense, according to Charla Krupp, noted beauty expert and best-selling author, in offering some "makeup makeover" tips and other advice to help rosacea sufferers look their best.
The National Rosacea Society (NRS) has published new standard patient care options for rosacea, developed by a consensus committee and review panel of 26 rosacea experts, and articles on the various options for controlling the many potential aspects of this widespread disorder will appear in future issues of Rosacea Review.1
196 James St.
Barrington, IL 60010
The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace
consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.